CR9627A - Cyanopyrrole-sulfonamide progesterone receptor modulators and uses thereof - Google Patents
Cyanopyrrole-sulfonamide progesterone receptor modulators and uses thereofInfo
- Publication number
- CR9627A CR9627A CR9627A CR9627A CR9627A CR 9627 A CR9627 A CR 9627A CR 9627 A CR9627 A CR 9627A CR 9627 A CR9627 A CR 9627A CR 9627 A CR9627 A CR 9627A
- Authority
- CR
- Costa Rica
- Prior art keywords
- receptor modulators
- progesterone receptor
- cyanopyrrole
- sulfonamide
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Abstract
Se describen los moduladores del receptor de la progesterona de formula (I), o una sal farmaceuticamente aceptable del mismo, Formula (I); en donde R1, R2, R3, R4, R5, R6 y R7 son como define en la presente, son utiles para la anticoncepcion y terapia de reemplazo hormonal; tambien se proporcionan productos que contienen estos compuestos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70400905P | 2005-07-29 | 2005-07-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
CR9627A true CR9627A (es) | 2008-03-06 |
Family
ID=37309001
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR9627A CR9627A (es) | 2005-07-29 | 2007-12-20 | Cyanopyrrole-sulfonamide progesterone receptor modulators and uses thereof |
Country Status (22)
Country | Link |
---|---|
US (1) | US7291643B2 (es) |
EP (1) | EP1910285A1 (es) |
JP (1) | JP5185114B2 (es) |
KR (1) | KR20080031915A (es) |
CN (1) | CN101233104A (es) |
AR (1) | AR056005A1 (es) |
AU (1) | AU2006275833B2 (es) |
BR (1) | BRPI0614412A2 (es) |
CA (1) | CA2612977A1 (es) |
CR (1) | CR9627A (es) |
EC (1) | ECSP088147A (es) |
GT (1) | GT200600336A (es) |
HN (1) | HN2008000135A (es) |
IL (1) | IL188314A (es) |
MX (1) | MX2008001338A (es) |
NO (1) | NO20076683L (es) |
PE (1) | PE20070404A1 (es) |
RU (1) | RU2007148077A (es) |
SA (1) | SA06270246B1 (es) |
TW (1) | TW200734302A (es) |
UA (1) | UA92500C2 (es) |
WO (1) | WO2007016212A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20070182A1 (es) * | 2005-07-29 | 2007-03-06 | Wyeth Corp | Derivados cianopirrol-fenil amida como moduladores del receptor de progesterona |
PE20070341A1 (es) * | 2005-07-29 | 2007-04-13 | Wyeth Corp | Derivados de pirrol como moduladores del receptor de progesterona |
TW200848019A (en) * | 2007-03-06 | 2008-12-16 | Wyeth Corp | Aryl sulfonamides useful for modulation of the progesterone receptor |
TW200848021A (en) * | 2007-03-06 | 2008-12-16 | Wyeth Corp | Sulfonylated heterocycles useful for modulation of the progesterone receptor |
CA2710293A1 (en) * | 2007-12-20 | 2009-07-02 | Teva Women's Health, Inc. | Dosage regimens and pharmaceutical compositions and packages for emergency contraception |
CN105101959B (zh) | 2012-11-05 | 2018-04-17 | 南特知识产权控股有限责任公司 | 作为刺猬信号传导通路的抑制剂的含有环状磺酰胺的衍生物 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4680413A (en) * | 1986-01-17 | 1987-07-14 | Nippon Soda Co., Ltd. | Process for the production of 3-phenyl-4-cyanopyrroles |
US5310938A (en) | 1987-07-29 | 1994-05-10 | American Cyanamid Company | Substituted arylpyrrole compounds |
EP0339342A1 (de) | 1988-04-23 | 1989-11-02 | Bayer Ag | N-Substituierte N-Amino-pyrrole |
GB8903592D0 (en) | 1989-02-16 | 1989-04-05 | Boots Co Plc | Therapeutic agents |
DE4036645A1 (de) | 1990-11-16 | 1992-05-21 | Hoechst Ag | Substituierte azole, verfahren zu deren herstellung, deren enthaltende mittel und deren verwendung |
JP2699024B2 (ja) | 1990-11-22 | 1998-01-19 | 富士写真フイルム株式会社 | 新規な色素形成カプラーおよび該カプラーを含有するハロゲン化銀カラー写真感光材料 |
US5236925A (en) | 1991-10-24 | 1993-08-17 | American Home Products Corporation | Fused pyrimidines as angiotensin II antagonists |
US5187168A (en) | 1991-10-24 | 1993-02-16 | American Home Products Corporation | Substituted quinazolines as angiotensin II antagonists |
AU5891494A (en) | 1993-01-29 | 1994-08-15 | Nippon Soda Co., Ltd. | Heterocyclic derivative |
KR100275222B1 (ko) | 1995-06-07 | 2001-02-01 | 이노세 히로시 | 피롤 유도체 및 의약 조성물 |
US6013421A (en) | 1996-07-19 | 2000-01-11 | Fuji Photo Film Co., Ltd. | Silver halide photographic light-sensitive material and image-forming method |
US20010007867A1 (en) | 1999-12-13 | 2001-07-12 | Yuhpyng L. Chen | Substituted 6,5-hetero-bicyclic derivatives |
US6407101B1 (en) * | 1999-05-04 | 2002-06-18 | American Home Products Corporation | Cyanopyrroles |
MXPA03008142A (es) | 2001-03-09 | 2003-12-12 | Pfizer Prod Inc | Nuevos compuestos antiinflamatorios de bencimidazol. |
ATE323701T1 (de) | 2001-03-09 | 2006-05-15 | Pfizer Prod Inc | Triazolopyridine als entzündungshemmende mittel |
DE60205974T2 (de) | 2001-04-04 | 2006-06-29 | Pfizer Products Inc., Groton | Neue Benzotriazole mit entzündungshemmender Wirkung |
JP2006514110A (ja) | 2002-11-11 | 2006-04-27 | バイエル・ヘルスケア・アクチェンゲゼルシャフト | Ip受容体アンタゴニストとしてのフェニルまたはヘテロアリールアミノアルカン誘導体 |
WO2004073594A2 (fr) | 2003-02-12 | 2004-09-02 | L'oreal | Utilisation d’un inhibiteur de 15-hydroxy prostaglandine deshydrogenase pour favoriser la pigmentation de la peau ou des phaneres |
US7582755B2 (en) | 2004-04-27 | 2009-09-01 | Wyeth | Cyanopyrrole-containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same |
GT200500185A (es) * | 2004-08-09 | 2006-04-10 | Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos | |
GT200500183A (es) * | 2004-08-09 | 2006-04-10 | Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos |
-
2006
- 2006-07-26 PE PE2006000915A patent/PE20070404A1/es not_active Application Discontinuation
- 2006-07-27 CN CNA2006800277588A patent/CN101233104A/zh active Pending
- 2006-07-27 WO PCT/US2006/029125 patent/WO2007016212A1/en active Application Filing
- 2006-07-27 US US11/494,226 patent/US7291643B2/en not_active Expired - Fee Related
- 2006-07-27 CA CA002612977A patent/CA2612977A1/en not_active Abandoned
- 2006-07-27 UA UAA200801075A patent/UA92500C2/ru unknown
- 2006-07-27 GT GT200600336A patent/GT200600336A/es unknown
- 2006-07-27 AU AU2006275833A patent/AU2006275833B2/en not_active Ceased
- 2006-07-27 EP EP06774705A patent/EP1910285A1/en not_active Withdrawn
- 2006-07-27 MX MX2008001338A patent/MX2008001338A/es active IP Right Grant
- 2006-07-27 JP JP2008524136A patent/JP5185114B2/ja not_active Expired - Fee Related
- 2006-07-27 BR BRPI0614412A patent/BRPI0614412A2/pt not_active IP Right Cessation
- 2006-07-27 RU RU2007148077/04A patent/RU2007148077A/ru not_active Application Discontinuation
- 2006-07-27 KR KR1020087002371A patent/KR20080031915A/ko not_active Application Discontinuation
- 2006-07-27 TW TW095127519A patent/TW200734302A/zh unknown
- 2006-07-27 AR ARP060103257A patent/AR056005A1/es not_active Application Discontinuation
- 2006-07-29 SA SA06270246A patent/SA06270246B1/ar unknown
-
2007
- 2007-12-20 IL IL188314A patent/IL188314A/en not_active IP Right Cessation
- 2007-12-20 CR CR9627A patent/CR9627A/es not_active Application Discontinuation
- 2007-12-28 NO NO20076683A patent/NO20076683L/no not_active Application Discontinuation
-
2008
- 2008-01-28 HN HN2008000135A patent/HN2008000135A/es unknown
- 2008-01-28 EC EC2008008147A patent/ECSP088147A/es unknown
Also Published As
Publication number | Publication date |
---|---|
AU2006275833B2 (en) | 2012-04-26 |
SA06270246B1 (ar) | 2010-11-22 |
NO20076683L (no) | 2008-02-04 |
AU2006275833A1 (en) | 2007-02-08 |
CA2612977A1 (en) | 2007-02-08 |
GT200600336A (es) | 2007-05-28 |
PE20070404A1 (es) | 2007-05-10 |
JP5185114B2 (ja) | 2013-04-17 |
EP1910285A1 (en) | 2008-04-16 |
KR20080031915A (ko) | 2008-04-11 |
AR056005A1 (es) | 2007-09-12 |
UA92500C2 (ru) | 2010-11-10 |
IL188314A (en) | 2012-09-24 |
BRPI0614412A2 (pt) | 2016-11-22 |
US7291643B2 (en) | 2007-11-06 |
IL188314A0 (en) | 2008-04-13 |
HN2008000135A (es) | 2010-08-19 |
MX2008001338A (es) | 2008-03-25 |
TW200734302A (en) | 2007-09-16 |
JP2009502947A (ja) | 2009-01-29 |
WO2007016212A1 (en) | 2007-02-08 |
RU2007148077A (ru) | 2009-09-10 |
ECSP088147A (es) | 2008-02-20 |
CN101233104A (zh) | 2008-07-30 |
US20070027126A1 (en) | 2007-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR057060A1 (es) | Composiciones de tanaproget que contienen etinil estradiol | |
CR9627A (es) | Cyanopyrrole-sulfonamide progesterone receptor modulators and uses thereof | |
ECSP088412A (es) | Derivados de pirazina como moduladores de canal de sodio en el tratamiento del dolor | |
CL2008000669A1 (es) | Compuestos derivados de tiazolidindionas n alquiladas, moduladores del receptor alfa relacionados con estrogenos; composicion farmaceutica; y su uso para tratar enfermedades relacionadas con los huesos, cancer, sindrome metabolicos, entre otras. | |
CR8517A (es) | Moduladores del receptor selectivo del estrogeno para el tratamiento de sintomas vasomotores | |
CL2011000835A1 (es) | Compuestos derivados de espiro-oxindol; moduladores de los canales de sodio; composicion farmaceutica que comprende a dicho compuesto; y uso en el tratamiento del dolor, depresion, enfermedades cardiovasculares, respiratorias, psiquiatricas, entre otras. | |
UY29875A1 (es) | Compuestos quimicos | |
UY26129A1 (es) | Moduladores del receptor glucocorticoide | |
UY29320A1 (es) | 18-metil-19-nor-17-pregn-4-en-21, 17-carbolactonas, así como preparaciones farmacéuticas que las contienen | |
UY31183A1 (es) | Derivados de pirazinona y procesos para su preparación | |
AR065135A1 (es) | Compuestos triciclicos, composicion que los comprende y su uso en la preparacion de un medicamento para el tratamiento de enfermedades mediadas por el receptor de glucocorticoides. | |
UY27436A1 (es) | Compuestos químicos | |
AR054786A1 (es) | (6-fluor-benzol(1,3) dioxolil)-morfolin-4-il-metanomas, moduladoras del receptor cb1 | |
ECSP077323A (es) | Nuevos derivados de sulfonamida como moduladores del receptor de glucocorticoides para el tratamiento de enfermedades inflamatorias | |
CL2011001658A1 (es) | Compuestos derivados de sulfonamidas, moduladores de los canales de sodio; composición farmacéutica que los comprende; y su uso en el tratamiento del dolor. | |
AR064692A1 (es) | Derivados de oxindol sustituido medicamentos que los comprenden y uso de los mismos | |
AR054586A1 (es) | Uso de moduladores del receptor de progesterona | |
CL2011000544A1 (es) | Compuestos derivados de benzamida n sustituida por heterociclo, ligandos de los receptores cannabinoides; composicion farmaceutica; y su uso para tratar el dolor, entre otras enfermedades. | |
UY30736A1 (es) | Compuestos quimicos 537 | |
ATE467632T1 (de) | Pyrroloä2,3-büpyridinderivate als modulatoren des h3-rezeptors | |
ECSP099425A (es) | Derivados de amina y su uso en enfermedades mediadas por el adrenorecetor beta 2 | |
GT200600335A (es) | Moduladores del receptor de progesterona cianopirrol-fenil amida y usos de los mismos | |
ECSP078043A (es) | Derivados de benzofurarona como moduladores no esteroides de receptores de progesterona | |
HN2009001441A (es) | Compuestos de 2- aminopirimidina como potentes inhibidores de hsp-90 | |
UY29625A1 (es) | Uso de moduladores no esteroides de receptores de progesterona |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal (granting procedure) |